Your browser doesn't support javascript.
loading
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical application.
Löffler, Mona C; Betz, Matthias J; Blondin, Denis P; Augustin, Robert; Sharma, Anand K; Tseng, Yu-Hua; Scheele, Camilla; Zimdahl, Heike; Mark, Michael; Hennige, Anita M; Wolfrum, Christian; Langhans, Wolfgang; Hamilton, Bradford S; Neubauer, Heike.
Afiliação
  • Löffler MC; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Betz MJ; Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
  • Blondin DP; Department of Medicine, Division of Neurology, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, QC, Canada.
  • Augustin R; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Sharma AK; Institute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.
  • Tseng YH; Joslin Diabetes Center, Section on Integrative Physiology and Metabolism, Harvard Medical School, Boston, MA, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
  • Scheele C; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark.
  • Zimdahl H; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Mark M; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Hennige AM; Therapeutic Area CardioMetabolism & Respiratory, Boehringer Ingelheim International GmbH, Biberach, Germany.
  • Wolfrum C; Institute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.
  • Langhans W; Physiology and Behavior Laboratory, Department of Health Sciences and Technology, ETH Zürich, Switzerland.
  • Hamilton BS; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Neubauer H; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. Electronic address: heike.neubauer@boehringer-ingelheim.com.
Mol Metab ; 51: 101237, 2021 09.
Article em En | MEDLINE | ID: mdl-33878401
ABSTRACT

BACKGROUND:

A chronic imbalance of energy intake and energy expenditure results in excess fat storage. The obesity often caused by this overweight is detrimental to the health of millions of people. Understanding both sides of the energy balance equation and their counter-regulatory mechanisms is critical to the development of effective therapies to treat this epidemic. SCOPE OF REVIEW Behaviors surrounding ingestion have been reviewed extensively. This review focuses more specifically on energy expenditure regarding bodyweight control, with a particular emphasis on the organs and attractive metabolic processes known to reduce bodyweight. Moreover, previous and current attempts at anti-obesity strategies focusing on energy expenditure are highlighted. Precise measurements of energy expenditure, which consist of cellular, animal, and human models, as well as measurements of their translatability, are required to provide the most effective therapies. MAJOR

CONCLUSIONS:

A precise understanding of the components surrounding energy expenditure, including tailored approaches based on genetic, biomarker, or physical characteristics, must be integrated into future anti-obesity treatments. Further comprehensive investigations are required to define suitable treatments, especially because the complex nature of the human perspective remains poorly understood.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ingestão de Energia / Metabolismo Energético / Obesidade Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ingestão de Energia / Metabolismo Energético / Obesidade Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article